Kori Kaufman
Director, Contracts Specialist | She/Her/Hers
Director, Contracts Specialist | She/Her/Hers
Areas of Focus
Overview
Clients benefit from Kori Kaufman’s more than 25 years of contracts experience in the pharmaceutical and biotechnology industries.
She assists clients with clinical trial, service, consulting, and related agreements for all stages of therapeutic product and medical device research and development.
Kori’s extensive clinical trial experience includes drafting, negotiating, and coordinating CRO and other vendor agreements, site clinical trial agreements, and informed consent forms for clinical studies ranging from a client’s first Phase 1 clinical study to complex, multinational, pivotal clinical trials with over 450 sites.
Career & Education
- Contracts Manager, Albany Molecular Research, Inc. (AMRI) (now Curia Global, Inc.)
- Responsible for agreements involving outsourced drug discovery and commercial manufacture of API
- Worked with AMRI’s international subsidiaries on corporate governance and compliance
- While a member of AMRI’s business development group, focused on proposal drafting and review, marketing and submissions for governmental contracts
- Kori completed doctorate level course work in anthropology at the University at Albany, State University of New York.
- Contracts Manager, Albany Molecular Research, Inc. (AMRI) (now Curia Global, Inc.)
- Brandeis University, B.A.,
cum laude
- Brandeis University, B.A.,
Representative Matters
- Supported numerous Phase 1 through 3 oncology clinical trials of multiple small molecules, including coordinating, drafting, and negotiating clinical trial agreements, clinical service agreements, informed consents, and related agreements for multinational trials involving sites in North America, Europe, South America, Asia, and Australia.
- Supported a clinical research and development company in a Phase 1b/2 clinical trial of their novel HDAC inhibitor targeting metastatic pancreatic adenocarcinoma involving approximately 20 sites in the United States.
- Assisted publicly traded biotechnology client with U.S. clinical trials at multiple dialysis centers focusing on additional indications of approved nephrology product.
- Assisted multiple clients in obtaining and reviewing advice from local and privacy counsel for clinical trial related agreements in Europe, Asia, and Latin America.
- Drafted and negotiated service agreements with service providers for clinical and preclinical studies, of therapeutic and medical device products, including start-up and master services agreements valued at over $500,000 with large, multinational contract research organizations.
